Order Article Reprints

Nagayoshi Y, Nishiguchi K, Yamamura R, Chujo T, Oshiumi H, Nagata H, Kaneko H, Yamamoto K, Nakata H, Sakakida K, et al. t⁶A and ms²t⁶A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity. Biomolecules. 2022; 12(9):1233. https://doi.org/10.3390/biom12091233

Nagayoshi, Yu, Kayo Nishiguchi, Ryosuke Yamamura, Takeshi Chujo, Hiroyuki Oshiumi, Hiroko Nagata, Hitomi Kaneko, Keiichi Yamamoto, Hirotomo Nakata, Korin Sakakida, and et al. 2022. "t⁶A and ms²t⁶A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity" Biomolecules 12, no. 9: 1233. https://doi.org/10.3390/biom12091233

Nagayoshi, Y., Nishiguchi, K., Yamamura, R., Chujo, T., Oshiumi, H., Nagata, H., Kaneko, H., Yamamoto, K., Nakata, H., Sakakida, K., Kunisawa, A., Adachi, M., Kakizoe, Y., Mizobe, T., Kuratsu, J.-i., Shimada, S., Nakamori, Y., Matsuoka, M., Mukoyama, M., ... Tomizawa, K. (2022). t⁶A and ms²t⁶A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity. Biomolecules, 12(9), 1233. https://doi.org/10.3390/biom12091233